Immune Response after 2 Doses of BNT162b2 mRNA COVID-19 Vaccinations in Children and Adolescents with Cancer and Hematologic Diseases.

Hansamon PoparnChonlatis SrichumpuangDarintr Sosothikul Watsamon Jantarabenjakul Supanun Lauhasurayotin Piti Techavichit Kanhatai Chiangthong Yong Poovorawan

Published in: Asian Pacific journal of cancer prevention : APJCP (2022)

After complete vaccination, the seroprotective rate and antibody level in pediatric and adolescent patients with cancer and hematologic disease who receive immunosuppressive agents are quite low, compared with patients who had complete treatment. Additional dose of primary series should be offered.

Keyphrases

immune response
coronavirus disease
sars cov
papillary thyroid
childhood cancer
young adults
mental health
squamous cell carcinoma
lymph node metastasis
respiratory syndrome coronavirus